Korean J Intern Med > Volume 13(1); 1998 > Article
Lim, Jo, Kim, Choi, Suh, Yoon, Moon, Won, Kwon, and Pyo: A Case of Wegener’s Granulomatosis Complicated by Diffuse Pulmonary Hemorrhage and Thrombotic Thrombocytopenic Purpura

Abstract

Wegener’s granulomatosis is a distinct form of necrotizing granulomatous vasculitis which usually affects the kidneys and the upper and lower respiratory tracts. Unusual manifestations have also been reported, and these include colitis, urethritis and diabetes insipidus. We describe a case of Wegener’s granulomatosis which presented with rapidly progressive renal insufficiency, sudden deafness, red eye, facial palsy, and complicated by uncommon manifestations that were diffuse pulmonary hemorrhage and thrombotic thrombocytopenic purpura.

INTRODUCTION

Wegener’s granulomatosis(WG) falls within the spectrum of systemic vasculitides as a clinicopathologic syndrome involving the upper and lower respiration tract and the kidney and, less commonly, the eyes, joints, skin, neurologic and cardiac tissue1). Diffuse pulmonary hemorrhage(DPH) is a relatively uncommon manifestation of WG but can be a first manifestation of WG24). We describe a case of WG diagnosed by pathologic finding and serologic marker(C-ANCA). While being treated, the patient was complicated by unusual manifestations of WG, including diffuse pulmonary hemorrhage and thrombotic thrombocytopenic purpura(TTP).

CASE REPORT

A 66-year-old woman presented on January 21, 1997 with abdominal pain, sudden deafness, facial palsy and oliguria. She had a 3-week history of nasal stuffness. Clinical examinations revealed no specific findings except red eye, nasal ulceration and high blood pressure(160/100mmHg). Plasma creatinine value was 6.2mg/dL and urinalysis showed many red blood cell and proteinuria (>300mg/dL). Erythrocyte sedimentation rate was 47mm/h; C-reactive protein 209ug/mL; leukocyte 13600/mm3 with 85% polymorphonuclear neutrophils; hemoglobin 9.9g/dL; platelet 221000/mm3. Rheumatoid factor, antinuclear antibodies, anti-ds DNA antibody and cryoglobulin were not detected. Complement concentrations(C3 and C4) were normal. Ultrasonography showed normal sized kidneys with no evidence of obstruction or cortical atrophy, and brain MRI showed no specific findings except for maxillary sinusitis. Serology showed ANCA positive (C-ANCA pattern) in a titer of 1:640 (Fig. 1) and nasal septal biopsy showed the necrotizing granulomatous vasculitis.(Fig. 2,3).
Therapy was initiated on January 22, with hemodialysis thrice weekly, and on January 25, with intravenous methylprednisolone 0.5g/day for 3 days, followed by prednisone 75mg/day(1mg/Kg) orally. Cyclophosphamide 150mg/day(2mg/Kg) was also given orally. She gradually improved but, on January 31, she complained of dyspnea. Chest X-ray showed homogeneous, ill-defined, patch consolidation on right lung field(Fig. 4). Hemoglobin was 5.0g/dL, platelet 157,000/mm3 and HRCT showed diffuse pulmonary hemorrhage(Fig. 5) and bronchoscopic examination showed fresh oozing blood from distal airway. Subsequently, diffuse pulmonary hemorrhage developed in left lung field. She was treated with transfusion to a hemoglobin of 10.8g/dL, ventilator care and second intravenous methlyprednisone 0.5g/day for 3 days. After that, prednisolone 75mg/day and cyclophosphamide 150mg/day were also given orally.
On February 5, the follow-up chest X-ray showed a much improved state but hemoglobin was decreased to 6.0g/dL; platelet 28,000/mm3. There was no clinical and laboratory evidence of hemorrhage, infection and disseminated intravascular coagulation. The peripheral blood smear showed many RBC fragments(Fig. 6); lactate dehydrogenase was increased to 902 IU/L(normal, <500IU/L) with LD1 flipped pattern; haptoglobin was reduced to below 5.8mg/L(normal, 16 to 20Omg/L); Coombs’ test and antiplatelet antibody were negative. Plasmapheresis was begun on February 10 and performed every day for 5 days.
By February 19, hemoglobin was 9.2g/dL; platelet was 141,000/mm3 without further transfusion; follow-up titer of C-ANCA was 1:40; ESR and CRP were 6mm/h and negative respectively. Oliguria and all systemic symptoms had been resolved. She remains on maintenance oral cyclophosphamide and tapering doses of prednisolone.

DISCUSSION

Recently, for prompt diagnosis and institution of treatment, patients who have circulating ANCA vasculitis and upper and lower respiratory tract symptoms have been designated as Wegener’s syndrome, including classic WG and WG vasculitis5). The major sites of involvement are ear, nose, throat, lung and kidney6). Other major sites of involvement include the skin, with a variety of manifestations, including leukocytoclastic vasculitis and pyoderma gangrenosum; the nervous system, the chief sign being mononeuritis multiplex; the eye, displaying redness indicative of scleritis or episcleritis; the orbit, with pseudotumor causing proptosis; and the joints, manifesting a mono- or polyarticular migratory arthritis6). Diffuse alveolar hemorrhage was reported in 4 cases among 27 cases with ANCA associated vasculitis5) and 6 cases among 77 WG cases7). Diffuse alveolar hemorrhage is manifestated characteristically with hemoptysis, breathlessness, a diffuse alveolar filling pattern on chest roentgenogram and a profound anemia, and developed in fulminant WG6). In diffuse alveolar infiltrate on chest roentgenogram in WG, careful differential diagnosis between alveolar hemorrhage and infections is needed.
In our case, DPH was diagnosed by clinical and laboratory features, HRCT and bronchoscopic findings. Bronchoscopic findings in 51 WG patients showed hemorrhage without identifiable source in 2 cases, such as our case, probably due to hemorrhagic alveolar capillaritis8). By analysis of clinicopathologic characteristics and ANCA in 43 patients with DPH, underlying diseases were idiopathic pulmonary-renal syndrome(l6 cases), WG(10 cases), polyarteritis(11 cases), and isolated pulmonary hemorrhage(6 cases)9). No patients showed thrombotic microangiopathy simultaneously.
In WG, other unusual manifestations have also been reported, and these include colitis, urethritis, diabetes inspidus and microangiopathic hemolytic anemia10). Thrombotic microangiopathy has been described in many conditions, including hemolytic uremic syndrome, progressive systemic sclerosis, postpartum renal failure, malignant hypertension, membranous glomerulonephritis, systemic lupus erythematosus, polyarteritis nodosa, certain malignancies, infections, bone marrow transplant, and secondary to drugs such as cyclosporine A and estrogens5). Our patient did not have evidence of these conditions.
Heptinstall11) has described a case of hemolytic uremic syndrome associated with crescent glomerulonephritis, but ANCA status was not reported. Stave and Croker12) have described thrombotic microangiopathy in 6 of 12 patients with anti-glomerular basement membrane glomerulonephritis. Benitez et al13) have reported a case of platelet thrombi in polyarteritis nodosa, including glomerular capillary thrombi. A case of thrombotic microangiopathy in P-ANCA positive crescsentic glomerulonephritis was described. By Hirsch et al14). Crummy et al15) reported the unusual manifestations of microangiopathic hemolytic anemia and consumptive coagulopathy in WG for the first time. Jordan et al10) also reported a case of WG in which the disease was manifested with crescentic glomerulonephitis, upper airway ulcerations, microangiopathic hemolytic anemia with consumptive coagulopathy and breast mass, but DPH was not identified.
When microscopic vessels were predominantly involved (capillaritis), Boudes et al16) referred to this particular form of the disease as "microscopic Wegener’s disease" Microscopic Wegener’s disease is characterized by the association of microscopic vasculitis involving renal capillary or other vessels, such as lung capillary(with alveolar hemorrhage), the occurrence of microangiopathic hemolytic anemia and consumptive coagulopathy, the presence of C-ANCA as in our case, but does not show prominent granuloma on the other hand. In this case, thrombotic microangiopathy and crescentic gromerulonephritis had not been confirmed by biopsy, but the occurrence of microangiopathic hemolytic anemia and consumptive coagulopathy was diagnosed by clinical features and laboratory findings. DPH improved after second steroid pulse but on the other hand, microangiopathic hemolytic anemia, thrombocytopenia and fluctuation of consciousness appeared. To our knowlege, this association in WG has not been previously described in worldwide literature.
The therapeutic aspect of our case also deserves mention. It is now widely recognized that the mainstay of therapy in WG is cyclophosphamide. Plasma exchanges could have a favorable role, but their efficacy in WG remains uncertain. But plasmapheresis is a prerequisite to treatment of TTP, irrespective of the primary underlying disease. This case is characterized by the association of microscopic vasculitis involving renal capillary or other vessels, such as lung capillary, or with the occurrence of microangiopathic hemolytic anemia and consumptive coagulopathy. This particular feature of our report should be evaluated in the rare patient who has active WG.

Fig. 1.
Positive C-ANCA in immunofluorescence testing(×100). Centrally accentuated finely granular cytoplasmic immunofluorescence is present in all neutrophils, with no stanining of neutrophil polymorphonuclear lobes.
kjim-13-1-68-13f1.gif
Fig. 2.
Nasal septal biopsy shows granulomatous inflammtion with central neutrophilic infiltration and surrounding zone of histiocytes in cental area. The peripheral area shows dense lymphocytic infiltration(H & E stain, ×100)
kjim-13-1-68-13f2.gif
Fig. 3.
Nasal septal biopsy shows the small vessels’ wall diffusely infiltrated with leukocytes, perivascular inflammation(H & E stain, ×400)
kjim-13-1-68-13f3.gif
Fig. 4.
Chest radiogaph shows diffuse air-space consolidation with air-bronchogram in the whole right lung field.
kjim-13-1-68-13f4.gif
Fig. 5.
HRCT of the chest shows nonsegmental ground glass opacity with air-bronchogram in the right lung field.
kjim-13-1-68-13f5.gif
Fig. 6.
Peripheral blood smear(Wright-Giemsa stain, ×1000) shows frequent irregular shaped erythrocyte fragments.
kjim-13-1-68-13f6.gif

REFERENCES

1. Allen NE. Wegener’s granulomatosis. In: Bennett J, Plum F, eds. Text of medicine. 2:20th ed. Philadelphia: WB saumders, 1996;1495–98.

2. Misset B, Glotz D, Escudier B, Nochy D, Bosq J, Gilles E, Lecleres B, Nitenberg G. Wegener’s granulomatosis presenting as diffuse pulmonary hemorrhage. Intensive Care Med 1991;17:118–20.
crossref pmid
3. Myers JL, Katzenstein AL. Wegener’s granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol 1987;11:702–708.
crossref pmid
4. Travis WD, Carpenter HA, Lie JT. Diffuse pulmonary hemorrhage. An uncommon manifestation of Wegener’s granulomatosis. Am J Surg Pathol 1987;11:895–898.
crossref pmid
5. Gaudin PB, Askin FB, Falle RJ, Jennette JC. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for antiproteinase 3 and anti-myeloperoxidase. Anatomic Pathol 1995;4:7–16.
crossref
6. DeRemee RA. Wegener’s granulomatosis. Curr Opinion Pulm Med 1995;1:363–367.

7. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener’s granulomatosis:A clinical and imaging study of 77 cases. Chest 1990;97:906–912.
crossref pmid
8. Daum TE, Specks U, Colby TV, Edell ES, Brutinel MW, Prakash U, De Remee RA. Tracheobronchial involvement in Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151:522–526.
crossref pmid
9. Bosch X, Lopez-Soto A, Mirapeix E, Font J, Ingelmo M, Urbano-Marquez A. Antineutrophil cytoplasmic autoantibody-associated alveolar capillarits in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994;118:517–22.
pmid
10. Jordan JM, Manning M, Bates Allen N. Multiple unusual manifestation of Wegener’s granulomatosis: breast mass, microangiopathic hemolytic anemia, comsumptive coagulopathy and low erythrocyte sedimentation rate. Arthritis Rheum 1986;29:1527–31.
crossref pmid
11. Heptinstall R. Hemolytic uremic syndrome. In: Heptinstall R, ed. Pathology of the Kidney. 4th ed. Boston: MA Little Brown, 1992;1163–1234.

12. Stave GM, Croker BP. Thromboric microangiopathy in anti-glomerular basement membrane glomerulonephritis. Arch Pathol Lab Med 1984;108:747–751.
pmid
13. Binitez L, Mathews M, Mallory Gk. Platelet thrombosis with polyarteritis nodosa. Arch Pathol 1964;77:166–125.
pmid
14. Hirsch DJ, Jindal K, Trillo A. Antineutrophil Cytoplasmic Antibody-positive Crescentic Glomerulonephritis and Thrombotic Microangiopathy. Am J Kid Dis 1995;26:385–386.
crossref pmid
15. Crummy CS, Perlin E, Moquin RB. Microangiopathic hemolytic anemia in Wegener’s granulomatosis. Am J Med 1971;51:544–8.
crossref pmid
16. Boudes P, Andre C, Belghiti D, Sobel A. Microscopic Wegener’s disease: A particular from of Wegener’s granulomatosis. J Rheumatol 1990;17:1412–14.
pmid

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by Korean Association of Internal Medicine.

Close layer
prev next